{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:04:14Z","timestamp":1790769854215,"version":"4.1.0"},"reference-count":18,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":21,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004326","name":"Bayer AG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To evaluate the feasibility and applicability of the studyathon format within a pharmaceutical company setting for generating reliable real-world evidence rapidly for a business-relevant research question.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>Conducted at Bayer, the studyathon assessed recurrent events following a first-ever transient ischemic attack. It involved an 8-week preparatory phase, a 1-week execution phase, and a 3-week post-event phase, using multiple real-world data sources.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The studyathon concluded successfully with a conference abstract submission. Key learnings included the importance of defining precise research questions, organizational alignment, thorough preparation, and leveraging diverse expertise and skill sets.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>The studyathon format proved suited for a pharmaceutical setting and revealed insights into its application. Our learnings highlight differences from multi-stakeholder community studyathons.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The studyathon demonstrated its potential as a valuable research approach within a pharmaceutical company. It improved study timelines and cross-functional collaboration while preserving scientific rigor.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jamiaopen\/ooag189","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T11:49:35Z","timestamp":1788954575000},"source":"Crossref","is-referenced-by-count":0,"title":["Advancing multi-database cohort studies: lessons learned from a studyathon in a pharmaceutical company"],"prefix":"10.1093","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9788-7266","authenticated-orcid":false,"given":"Elif","family":"Inan-Eroglu","sequence":"first","affiliation":[{"name":"Pharmaceuticals, Global Medical & Evidence, Bayer AG, 13353 Berlin,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5355-0474","authenticated-orcid":false,"given":"Daloha","family":"Rodriguez-Molina","sequence":"additional","affiliation":[{"name":"Pharmaceuticals, Global Medical & Evidence, Bayer AG, 13353 Berlin,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3596-6273","authenticated-orcid":false,"given":"Khaled","family":"Abdelgawwad","sequence":"additional","affiliation":[{"name":"Pharmaceuticals, Global Medical & Evidence, Bayer AG, 13353 Berlin,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2056-2713","authenticated-orcid":false,"given":"Carina","family":"Dinkel-Keuthage","sequence":"additional","affiliation":[{"name":"Pharmaceuticals, Global Medical & Evidence, Bayer AG, 13353 Berlin,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3825-0182","authenticated-orcid":false,"given":"Montse","family":"Soriano Gabarr\u00f3","sequence":"additional","affiliation":[{"name":"Pharmaceuticals, Global Medical & Evidence, Bayer AG, 13353 Berlin,","place":["Germany"]},{"name":"Current affiliation: Independent Researcher , 14482 Potsdam,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5822-2453","authenticated-orcid":false,"given":"Pareen","family":"Vora","sequence":"additional","affiliation":[{"name":"Pharmaceuticals, Global Medical & Evidence, Bayer AG, 13353 Berlin,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7299-7300","authenticated-orcid":false,"given":"Gianmario","family":"Candore","sequence":"additional","affiliation":[{"name":"Pharmaceuticals, Global Medical & Evidence, Bayer AG, 13353 Berlin,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0248-7636","authenticated-orcid":false,"given":"David","family":"Vizcaya","sequence":"additional","affiliation":[{"name":"Pharmaceuticals, Global Medical & Evidence, Bayer Hispania SL , 08970 Sant Joan Desp\u00ed,","place":["Spain"]},{"name":"Current affiliation: Alexion Pharmaceuticals SL , 08029 Barcelona,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3647-5326","authenticated-orcid":false,"given":"Katrin","family":"Manlik","sequence":"additional","affiliation":[{"name":"Pharmaceuticals, Global Medical & Evidence, Bayer AG, 13353 Berlin,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"key":"2026093007505365000_ooag189-B1","author":"OHDSI","year":"2019"},{"key":"2026093007505365000_ooag189-B2","doi-asserted-by":"publisher","first-page":"ooac100","DOI":"10.1093\/jamiaopen\/ooac100","article-title":"Evaluating a novel approach to stimulate open science collaborations: a case series of \u201cstudy-a-thon\u201d events within the OHDSI and European IMI communities","volume":"5","author":"Hughes","year":"2022","journal-title":"JAMIA Open."},{"key":"2026093007505365000_ooag189-B3","author":"The European Health Data & Evidence Network (EHDEN)","year":"2026"},{"key":"2026093007505365000_ooag189-B4","doi-asserted-by":"publisher","first-page":"e229","DOI":"10.1016\/S2665-9913(19)30075-X","article-title":"Opioid use, postoperative complications, and implant survival after unicompartmental versus total knee replacement: a population-based network study","volume":"1","author":"Burn","year":"2019","journal-title":"Lancet Rheumatol."},{"key":"2026093007505365000_ooag189-B5","doi-asserted-by":"publisher","first-page":"3068","DOI":"10.1007\/s00167-021-06799-y","article-title":"90-Day all-cause mortality can be predicted following a total knee replacement: an international, network study to develop and validate a prediction model","volume":"30","author":"Williams","year":"2022","journal-title":"Knee Surg Sports Traumatol Arthrosc."},{"key":"2026093007505365000_ooag189-B6","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/1745-6215-14-292","article-title":"Total or partial knee arthroplasty trial\u2014TOPKAT: study protocol for a randomised controlled trial","volume":"14","author":"Beard","year":"2013","journal-title":"Trials."},{"key":"2026093007505365000_ooag189-B7","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1007\/s40264-023-01353-w","article-title":"Supporting pharmacovigilance signal validation and prioritization with analyses of routinely collected health data: lessons learned from an EHDEN network study","volume":"46","author":"Gauffin","year":"2023","journal-title":"Drug Saf."},{"key":"2026093007505365000_ooag189-B8","author":"EHDEN: COVID-19 Study-a-thon 2020"},{"key":"2026093007505365000_ooag189-B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s43441-025-00854-3","article-title":"A regulatory perspective on a UK federated data network for medicines and medical devices: lessons from a \u2018study-a-thon\u2019","volume":"60","author":"Booth","year":"2026","journal-title":"Ther Innov Regul Sci"},{"key":"2026093007505365000_ooag189-B10","doi-asserted-by":"publisher","DOI":"10.1161\/str.56.suppl_1.TP273","article-title":"Abstract TP273: characteristics and incidence of stroke and bleeding in patients with a first-ever transient ischemic attack: a US multi-database observational study","volume":"56","author":"Abdelgawwad","year":"2025","journal-title":"Stroke"},{"key":"2026093007505365000_ooag189-B11","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jaccao.2022.10.014","article-title":"Effectiveness and safety of rivaroxaban and low molecular weight heparin in cancer-associated venous thromboembolism","volume":"5","author":"Coleman","year":"2023","journal-title":"JACC CardioOncol."},{"key":"2026093007505365000_ooag189-B12","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.amjmed.2024.02.005","article-title":"Comparative safety and effectiveness of reduced doses of direct acting oral anticoagulants for stroke prevention in atrial fibrillation","volume":"137","author":"Skj\u00f8th","year":"2024","journal-title":"Am J Med."},{"key":"2026093007505365000_ooag189-B13","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.23889\/ijpds.v8i1.2144","article-title":"Identification of international society on thrombosis and haemostasis major and clinically relevant non-major bleed events from electronic health records: a novel algorithm to enhance data utilisation from real-world sources","volume":"8","author":"Hartenstein","year":"2023","journal-title":"Int J Popul Data Sci."},{"key":"2026093007505365000_ooag189-B14","author":"Observational Health Data Sciences and Informatics"},{"key":"2026093007505365000_ooag189-B15","doi-asserted-by":"publisher","first-page":"966","DOI":"10.3233\/SHTI231108","article-title":"Health-analytics data to evidence suite (HADES): open-source software for observational research","volume":"310","author":"Schuemie","year":"2024","journal-title":"Stud Health Technol Inform."},{"key":"2026093007505365000_ooag189-B16","author":"Darwin EU\u00ae Public Code Repository"},{"key":"2026093007505365000_ooag189-B17","author":"Rodriguez-Molina"},{"key":"2026093007505365000_ooag189-B18","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1055\/a-2710-4226","article-title":"Best practices to design, plan, and execute large-scale federated analyses\u2013key learnings and suggestions from a study comprising 52 databases","volume":"16","author":"Burkard","year":"2025","journal-title":"Appl Clin Inform."}],"container-title":["JAMIA Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jamiaopen\/article-pdf\/9\/5\/ooag189\/71518591\/ooag189.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jamiaopen\/article-pdf\/9\/5\/ooag189\/71518591\/ooag189.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:51:00Z","timestamp":1790769060000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jamiaopen\/article\/doi\/10.1093\/jamiaopen\/ooag189\/8853721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,9]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9,9]]}},"URL":"https:\/\/doi.org\/10.1093\/jamiaopen\/ooag189","relation":{},"ISSN":["2574-2531"],"issn-type":[{"value":"2574-2531","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,9,9]]},"article-number":"ooag189"}}